ENSG00000244734


Homo sapiens

Features
Gene ID: ENSG00000244734
  
Biological name :HBB
  
Synonyms : HBB / hemoglobin subunit beta / P68871
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 11
Strand: -1
Band: p15.4
Gene start: 5225464
Gene end: 5229395
  
Corresponding Affymetrix probe sets: 1562981_at (Human Genome U133 Plus 2.0 Array)   209116_x_at (Human Genome U133 Plus 2.0 Array)   211696_x_at (Human Genome U133 Plus 2.0 Array)   217232_x_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000488004
Ensembl peptide - ENSP00000496200
Ensembl peptide - ENSP00000494175
Ensembl peptide - ENSP00000333994
Ensembl peptide - ENSP00000369671
NCBI entrez gene - 3043     See in Manteia.
OMIM - 141900
RefSeq - NM_000518
RefSeq Peptide - NP_000509
swissprot - D9YZU5
swissprot - A0A0J9YWK4
swissprot - F8W6P5
swissprot - P68871
Ensembl - ENSG00000244734
  
Related genetic diseases (OMIM): 141749 - Delta-beta thalassemia, 141749
  617980 - Erythrocytosis 6, 617980
  140700 - Heinz body anemia, 140700
  617971 - Methmoglobinemia, beta type, 617971
  603903 - Sickle cell anemia, 603903
  613985 - Thalassemia, beta, 613985
  603902 - Thalassemia-beta, dominant inclusion-body, 603902
  611162 - {Malaria, resistance to}, 611162
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 AL935210.1ENSDARG00000087390Danio rerio
 hbba1ENSDARG00000097238Danio rerio
 hbba1ENSDARG00000089087Danio rerio
 hbba2ENSDARG00000069734Danio rerio
 hbbe1.1ENSDARG00000113599Danio rerio
 hbbe1.2ENSDARG00000115405Danio rerio
 hbbe2ENSDARG00000045143Danio rerio
 hbbe3ENSDARG00000038147Danio rerio
 HBBAENSGALG00000028273Gallus gallus
 HBBRENSGALG00000017347Gallus gallus
 Hbb-bsENSMUSG00000052305Mus musculus
 Hbb-btENSMUSG00000073940Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
HBD / P02042 / hemoglobin subunit deltaENSG0000022360993
HBE1 / P02100 / hemoglobin subunit epsilon 1ENSG0000021393176
AC104389.5ENSG0000028493173
HBG2 / P69892 / hemoglobin subunit gamma 2ENSG0000019656573
HBG1 / P69891 / hemoglobin subunit gamma 1ENSG0000021393473
HBA2 / P69905 / hemoglobin subunit alpha 2ENSG0000018853644
HBA1 / P69905 / hemoglobin subunit alpha 1ENSG0000020617244
HBQ1 / P09105 / hemoglobin subunit theta 1ENSG0000008650638
HBZ / P02008 / hemoglobin subunit zetaENSG0000013065637
HBM / Q6B0K9 / hemoglobin subunit muENSG0000020617733


Protein motifs (from Interpro)
Interpro ID Name
 IPR000971  Globin
 IPR002337  Haemoglobin, beta-type
 IPR009050  Globin-like superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006898 receptor-mediated endocytosis TAS
 biological_processGO:0007596 blood coagulation TAS
 biological_processGO:0008217 regulation of blood pressure IEA
 biological_processGO:0010942 positive regulation of cell death IDA
 biological_processGO:0015671 oxygen transport IEA
 biological_processGO:0015701 bicarbonate transport TAS
 biological_processGO:0030185 nitric oxide transport NAS
 biological_processGO:0042542 response to hydrogen peroxide IDA
 biological_processGO:0042744 hydrogen peroxide catabolic process IDA
 biological_processGO:0043312 neutrophil degranulation TAS
 biological_processGO:0045429 positive regulation of nitric oxide biosynthetic process NAS
 biological_processGO:0050880 regulation of blood vessel size IEA
 biological_processGO:0051291 protein heterooligomerization IDA
 biological_processGO:0070293 renal absorption IMP
 biological_processGO:0070527 platelet aggregation HMP
 biological_processGO:0098869 cellular oxidant detoxification IEA
 cellular_componentGO:0005576 extracellular region TAS
 cellular_componentGO:0005615 extracellular space IDA
 cellular_componentGO:0005829 cytosol TAS
 cellular_componentGO:0005833 hemoglobin complex IEA
 cellular_componentGO:0031838 haptoglobin-hemoglobin complex IDA
 cellular_componentGO:0070062 extracellular exosome HDA
 cellular_componentGO:0071682 endocytic vesicle lumen TAS
 cellular_componentGO:0072562 blood microparticle HDA
 cellular_componentGO:1904724 tertiary granule lumen TAS
 cellular_componentGO:1904813 ficolin-1-rich granule lumen TAS
 molecular_functionGO:0004601 peroxidase activity IDA
 molecular_functionGO:0005344 oxygen carrier activity IEA
 molecular_functionGO:0005506 iron ion binding IEA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0019825 oxygen binding IEA
 molecular_functionGO:0020037 heme binding IEA
 molecular_functionGO:0030492 hemoglobin binding IDA
 molecular_functionGO:0031720 haptoglobin binding IDA
 molecular_functionGO:0046872 metal ion binding IEA


Pathways (from Reactome)
Pathway description
Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Scavenging of heme from plasma
Neutrophil degranulation
Factors involved in megakaryocyte development and platelet production


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000083 Renal failure 
Show

 HP:0000164 Abnormality of the teeth "Any abnormality of the primary (deciduous) or permanent teeth." [HPO:curators]
Show

 HP:0000365 Hearing loss 
Show

 HP:0000488 Retinopathy 
Show

 HP:0000505 Impaired vision 
Show

 HP:0000518 Cataract "A cataract is an opacity or clouding that develops in the crystalline `lens` (FMA:58241) of the eye or in its `capsule` (FMA:58881)." [HPO:probinson]
Show

 HP:0000582 Upslanting palpebral fissures 
Show

 HP:0000662 Night blindness 
Show

 HP:0000707 Neurological abnormality "An abnormality of the central or peripheral nervous system." [HPO:curators]
Show

 HP:0000716 Depression "A condition characterized by pervasive dysphoric mood, loss of interests, and inability to experience pleasure." [HPO:curators]
Show

 HP:0000739 Anxiety 
Show

 HP:0000765 Abnormality of the thorax "Any abnormality of the thorax (the region of the body formed by the sternum, the thoracic vertebrae and the ribs)." [HPO:curators]
Show

 HP:0000790 Hematuria "The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine)." [HPO:curators]
Show

 HP:0000819 Diabetes mellitus 
Show

 HP:0000821 Hypothyroidism 
Show

 HP:0000823 Delayed puberty 
Show

 HP:0000829 Hypoparathyroidism 
Show

 HP:0000846 Adrenal insufficiency 
Show

 HP:0000864 Abnormality of the hypothalamus-pituitary axis 
Show

 HP:0000924 Abnormality of the musculoskeletal system "An abnormality of the musculoskeletal system including one or more abnormalities affecting bones, muscles, cartilage, tendons, ligaments, joints, and other connective tissue." [HPO:curators]
Show

 HP:0000939 Osteoporosis "Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO, osteoporosis is characterized by a value of BMD 2.5 standard deviations or more below the young adult mean." [HPO:curators]
Show

 HP:0000952 Jaundice "Yellow pigmentation of the skin or sclera due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream." [HPO:curators]
Show

 HP:0000980 Pallor 
Show

 HP:0001081 Cholelithiasis 
Show

 HP:0001297 Stroke 
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001394 Cirrhosis 
Show

 HP:0001396 Cholestasis 
Show

 HP:0001638 Cardiomyopathy 
Show

 HP:0001640 Cardiomegaly 
Show

 HP:0001743 Abnormality of the spleen 
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0001875 Neutropenia 
Show

 HP:0001878 Hemolytic anemia 
Show

 HP:0001891 Iron deficiency anemia 
Show

 HP:0001894 Thrombocytosis 
Show

 HP:0001903 Anemia 
Show

 HP:0001923 Reticulocytosis 
Show

 HP:0001930 Nonspherocytic hemolytic anemia 
Show

 HP:0001935 Microcytic anemia 
Show

 HP:0001939 Metabolism abnormality 
Show

 HP:0001945 Fever 
Show

 HP:0001971 Hypersplenism 
Show

 HP:0001974 Leukocytosis "An abnormal increase in the number of `leukocytes` (CL:0000738) in the `blood` (FMA:9670)." [HPO:probinson]
Show

 HP:0002024 Malabsorption 
Show

 HP:0002027 Abdominal pain 
Show

 HP:0002092 Pulmonary hypertension 
Show

 HP:0002094 Dyspnea 
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002597 Abnormality of the vasculature 
Show

 HP:0002652 Skeletal dysplasia 
Show

 HP:0002718 Recurrent bacterial infections 
Show

 HP:0002719 Recurrent infections 
Show

 HP:0002721 Immunodeficiency 
Show

 HP:0002754 Osteomyelitis 
Show

 HP:0002829 Arthralgia 
Show

 HP:0002857 Genu valgum 
Show

 HP:0002896 Liver cancer 
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0003259 Increased creatinine 
Show

 HP:0003281 Increased serum ferritin 
Show

 HP:0003330 Abnormal bone laboratory examination 
Show

 HP:0003401 Paresthesia "Abnormal sensations such as tingling, pricking, or numbness of the skin with no apparent physical cause." [HPO:curators]
Show

 HP:0004840 hypochromic, microcytic anemia 
Show

 HP:0004870 chronic hemolytic anemia 
Show

 HP:0004936 Venous thrombosis 
Show

 HP:0005280 Depressed nasal root and bridge 
Show

 HP:0005511 Congenital heinz body anemia 
Show

 HP:0005518 Erythrocyte macrocytosis 
Show

 HP:0006543 Cardiorespiratory arrest 
Show

 HP:0007803 Congenital complete achromatopsia 
Show

 HP:0008282 Unconjugated hyperbilirubinemia 
Show

 HP:0008346 Increased red cell sickling tendency 
Show

 HP:0010620 Prominent malar region "Increased prominence of the malar region (cheeks)." [HPO:curators]
Show

 HP:0010885 Aseptic necrosis "A disease where there is cellular death (necrosis) of bone components due to interruption of the blood supply." [HPO:sdoelken]
Show

 HP:0011675 Arrhythmia "Any cardiac rhythm other than the normal sinus rhythm. Such a rhythm may be either of sinus or ectopic origin and either regular or irregular. An arrhythmia may be due to a disturbance in impulse formation or conduction or both." [DDD:dbrown, pmid:19063792]
Show

 HP:0011902 Abnormal hemoglobin "Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes." [HPO:probinson]
Show

 HP:0011904 Persistence of hemoglobin F "Hemoglobin F (HbF) contains two globin alpha chains and two globin gamma chains. It is the main form of hemoglobin in the fetus during the last seven months of intrauterine development and in the half year of postnatal life. In adults it normally makes up less than one percent of all hemoglobiin. This term refers to an increase in HbF above this limit. In beta thalassemia major, it may represent over 90 percent of all hemoglobin, and in beta thalassemia minor it may make up between 0.5 to 4 percent." [HPO:probinson]
Show

 HP:0011906 Reduced beta/alpha synthesis ratio "A reduction in the ratio of production of beta globin to that of alpha globin. This is the major abnormality in the various forms of beta thalassemia." [HPO:probinson, pmid:1060068]
Show

 HP:0011907 Reduced alpha/beta synthesis ratio "A reduction in the ratio of production of alpha globin to that of beta globin. This is the major abnormality in the various forms of alpha thalassemia." [HPO:probinson]
Show

 HP:0011968 Feeding difficulties "Impaired ability to eat related to problems gathering food and getting ready to suck, chew, or swallow it." [ISCA:eriggs]
Show

 HP:0011981 Pigment gallstones "Gallstones composed primarily of bilirubin and calcium salts (calcium bilirubinate) with a low cholesterol concentration." [HPO:probinson, pmid:12950109]
Show

 HP:0012418 Hypoxemia "An abnormally low level of blood oxygen." [HPO:probinson]
Show

 HP:0045040 Abnormal lactate dehydrogenase activity 
Show

 HP:0100749 Chest pain 
Show

 HP:0200023 Priapism "A painful and harmful medical condition in which the erect penis doesn t return to its flaccid state, despite the absence of both physical and psychological stimulation, within four hours." [HPO:SKOEHLER]
Show

 HP:0200042 skin ulcer "A discontinuity of the skin exhibiting complete loss of the epidermis and often portions of the dermis and even subcutaneous fat." [HPO:SKOEHLER]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000188536 HBA2 / P69905 / hemoglobin subunit alpha 2  / complex / reaction
 ENSG00000166394 CYB5R2 / Q6BCY4 / cytochrome b5 reductase 2  / reaction
 ENSG00000215883 CYB5RL / Q6IPT4 / cytochrome b5 reductase like  / reaction
 ENSG00000244734 HBB / P68871 / hemoglobin subunit beta  / complex / reaction
 ENSG00000257017 HP / P00738 / haptoglobin  / complex / reaction
 ENSG00000110169 HPX / P02790 / hemopexin  / reaction
 ENSG00000177575 CD163 / Q86VB7 / CD163 molecule  / complex / reaction
 ENSG00000159348 CYB5R1 / Q9UHQ9 / cytochrome b5 reductase 1  / reaction
 ENSG00000065615 CYB5R4 / Q7L1T6 / cytochrome b5 reductase 4  / reaction






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr